Menu
Doctor's prescription
Betina®
Download Leaflet Listen leaflet
Find here loading...
Eg capsules, pills, syrup, 10mg, etc.
Eurofarma does not sell directly to consumers. The prices presented here are for information purposes only and should be checked directly on the offerors website
{{ sku.name }}
In Stock
Find it now
Product Package Image
Image for illustrative purposes only.
Indication
Betina® (dicloridrato de betaistina) é indicado para: - Tratamento da Síndrome de Ménière caracterizada pela tríade de sintomas: Vertigem (com náuseas e vômito); Zumbido nos ouvidos; Perda ou dificuldade de audição. - Tratamento sintomático da tontura de origem vestibular.
Active Ingredient
dicloridrato de betaistina)
Concentration
16 mg e 24 mg
Presentation
Cada comprimido contém 16 mg e 24 mg de dicloridrato de betaistina em embalagens com 20 ou 30 comprimidos.
Practical information
Pills
Anti-vertigo
Sale under medical prescription
Doctor's prescription
Contraindication
Betina® (dicloridrato de betaistina) é contraindicando para uso por pacientes com hipersensibilidade conhecida à substância ativa ou a qualquer um dos excipientes, e com feocromocitoma.
Conscious Use of Medications Manual
So that you can take better care of yourself and those you love, following a safe and effective treatment, we present the manual on the conscious use of medicines. The publication brings together a series of extremely relevant information, presented in a simple and educational way. Access the manual here
Published in: September 23, 2016 
and updated in: July 24, 2024
Se persistirem os sintomas, o médico deverá ser consultado.
Registration 1.0043.1088
Eurofarma
About The Company Areas of Expertise Join Our Staff Media Eurofarma Certifications Warnings Awards and Recognition Visitation Program Where We Operate Press Office Programa +Diverso
Products
Generic Drugs Hospital Nonprescription Drugs Oncology Prescription Drugs
Innovation
Biotechnology Eurolab New Business Conduct Clinical Research With Us Research and Development EurON
Sustainability
Sustainable Report Corporate Governance Environment Annual Report Corporate Responsibility Sustainability Vision Balance Sheet
© Eurofarma 2024
Privacy Policy